Aspen Aerogels, Inc.
Here’s whether Aspen Aerogels, Inc. (ASPN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.
Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.92% over 10 days); 3-month momentum positive (+31.4%). Concerns: trading below the 200-day MA (long-term downtrend); weak 1-year return of -23.1%; rising volume on a downtrend (distribution, 1.19x avg). Currently 56.3% off its 52-week high. Score: +0/7.
ASPN is trading below its 200-day MA ($4.97) — a key warning sign the longer-term trend is under pressure. An RSI of 69.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -23.1% compares to +27.9% for SPY (trailed the market by 50.9%). The current 56.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.